Literature DB >> 11119477

Coronary Disease: Acute myocardial infarction: failed thrombolysis.

M A de Belder1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11119477      PMCID: PMC1729601          DOI: 10.1136/heart.85.1.104

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  20 in total

Review 1.  Acute myocardial infarction: thrombolysis.

Authors:  E J Topol
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

2.  Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences.

Authors:  S G Ellis; E R Da Silva; C M Spaulding; M Nobuyoshi; B Weiner; J D Talley
Journal:  Am Heart J       Date:  2000-06       Impact factor: 4.749

3.  Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I trial.

Authors:  R M Califf; E J Topol; B S George; J M Boswick; K L Lee; D Stump; J Dillon; C Abbottsmith; R J Candela; D J Kereiakes
Journal:  Circulation       Date:  1988-05       Impact factor: 29.690

4.  Failure of thrombolysis by streptokinase: detection with a simple electrocardiographic method.

Authors:  A G Sutton; P G Campbell; D J Price; E D Grech; J A Hall; A Davies; M J Stewart; M A de Belder
Journal:  Heart       Date:  2000-08       Impact factor: 5.994

5.  Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study.

Authors:  F Vermeer; A J Oude Ophuis; E J vd Berg; L G Brunninkhuis; C J Werter; A G Boehmer; A H Lousberg; W R Dassen; F W Bär
Journal:  Heart       Date:  1999-10       Impact factor: 5.994

Review 6.  Overcoming thrombolytic resistance: rationale and initial clinical experience combining thrombolytic therapy and glycoprotein IIb/IIIa receptor inhibition for acute myocardial infarction.

Authors:  C P Cannon
Journal:  J Am Coll Cardiol       Date:  1999-11-01       Impact factor: 24.094

7.  Reappraising the role of immediate intervention following thrombolytic recanalization in acute myocardial infarction.

Authors:  E D Grech; A G Sutton; P G Campbell; V J Ashton; D J Price; J A Hall; M A de Belder
Journal:  Am J Cardiol       Date:  2000-08-15       Impact factor: 2.778

8.  Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group.

Authors:  R M Califf; E J Topol; R S Stack; S G Ellis; B S George; D J Kereiakes; J K Samaha; S J Worley; J L Anderson; L Harrelson-Woodlief
Journal:  Circulation       Date:  1991-05       Impact factor: 29.690

Review 9.  Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction?

Authors:  A M Lincoff; E J Topol
Journal:  Circulation       Date:  1993-09       Impact factor: 29.690

10.  Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study Group.

Authors:  E M Ohman; B S George; C J White; M J Kern; P A Gurbel; R J Freedman; C Lundergan; J R Hartmann; J D Talley; M J Frey
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

View more
  6 in total

1.  The significance of circulating levels of both cardiac troponin I and high-sensitivity C reactive protein for the prediction of intravenous thrombolysis outcome in patients with ST-segment elevation myocardial infarction.

Authors:  S G Foussas; M N Zairis; S S Makrygiannis; S J Manousakis; F A Anastassiadis; C S Apostolatos; N G Patsourakos; M P Glyptis; J K Papadopoulos; D C Xenos; E N Adamopoulou; C D Olympios; S K Argyrakis
Journal:  Heart       Date:  2007-03-07       Impact factor: 5.994

2.  Clinical implications of ST-segment non-resolution after thrombolysis for myocardial infarction.

Authors:  L Bhatia; G J Clesham; D R Turner
Journal:  J R Soc Med       Date:  2004-12       Impact factor: 18.000

3.  Frequency of Non-ST Segment Elevation Myocardial Infarction (NSTEMI) in Acute Coronary Syndrome With Normal Electrocardiogram (ECG): Insights From a Cardiology Hospital in Pakistan.

Authors:  Rozi Khan; Junaid Akhter; Ussama Munir; Talal Almas; Waqas Ullah
Journal:  Cureus       Date:  2020-06-22

4.  Evaluation of the tolerability and effectiveness of Tenecteplase in patients with ST-Segment-Elevation Myocardial Infarction in a Secondary Hospital in Malaysia: A Retrospective Case Series.

Authors:  Kin Wei Chua; Sreevali Muthuvadivelu; Rosilawati Abdul Rani; Siew Chin Ong; Narwani Hussin; Wee Kooi Cheah
Journal:  Curr Ther Res Clin Exp       Date:  2021-08-21

Review 5.  Predictive model of increased mortality and bed occupancy if thrombolysis becomes the initial treatment strategy for STEMI during the SARS-CoV-2 pandemic.

Authors:  Luke Dancy; Kevin O'Gallagher; Matthew Ryan; Philip A MacCarthy; Ajay M Shah
Journal:  Clin Med (Lond)       Date:  2020-07-27       Impact factor: 2.659

6.  Successful medical management of a left ventricular thrombus and aneurysm following failed thrombolysis in myocardial infarction.

Authors:  Adebayo T Oyedeji; Christopher Lee; Olukolade O Owojori; Olabanji J Ajegbomogun; Adeseye A Akintunde
Journal:  Clin Med Insights Cardiol       Date:  2013-02-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.